← All organizations

EpiCept Corporation

For profit

Highest phase reached

Phase 2

First clinical trial

Dec 1, 2006

Last known activity

Mar 1, 2011

Acquired by Immune PharmaceuticalsUnited General Ltd on Nov 8, 2012

Timeline

1990s

  1. Sep 1, 1993

    EpiCept Corporation— Founded

2000s

  1. Sep 12, 2005

    Maxim Pharmaceuticals— Acquired

2010s

  1. Nov 8, 2012

    Immune Pharmaceuticals— Acquired By

2020s

  1. Mar 29, 2021

    United General Ltd— Now

Drugs by trial phase (7 distinct, 7 trials)

Phase 4 (0 own, 2 via acquisition)

Phase 2 (4 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (5)

Details

Founded
Englewood Cliffs, NJ, US Sep 1, 1993
Last known activity
Mar 1, 2011